Design of the subpopulations and intermediate outcomes in copd study (SPIROMICS)

Thorax

Volumn 69, Issue 5, 2014, Pages 491-494

  Couper, David ^a   LaVange, Lisa M ^a   Han, MeiLan ^b   Barr, R Graham ^c   Bleecker, Eugene ^d   Hoffman, Eric A ^e   Kanner, Richard ^f   Kleerup, Eric ^g   Martinez, Fernando J ^h   Woodruff, Prescott G ⁱ   Rennard, Stephen ^j  

^a IL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COPD EPIDEMIOLOGY; COPD EXACERBATIONS; EMPHYSEMA; IMAGING/CT MRI ETC;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84898914338     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203897     Document Type: Article

References (5)

1. Minino A, Xu J, Kochanek M. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010;59:1-71.
2. Global Strategy for Diagnosis, Management and Prevention of COPD (updated 2013). 2013. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013- Feb20.pdf (accessed 4 September 2013).
3. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43.
4. Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently. Am J Respir Crit Care Med 2010;182:863-4.
5. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE). Eur Respir J 2008;31:869-73.